What is the specificity of a low Pregnancy Associated Plasma Protein-A (PAPP-A) multiple of median (MoM) value in a pregnant woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Specificity of Low PAPP-A MoM Values

Low PAPP-A values demonstrate high specificity (81.6%) but poor sensitivity (38.7%) for predicting adverse pregnancy outcomes, meaning that while an abnormal result is meaningful, most adverse outcomes occur in women with normal PAPP-A levels. 1

Understanding PAPP-A Specificity in Clinical Context

The specificity of PAPP-A testing varies significantly based on the cutoff value chosen and the population studied:

Standard Cutoff Values and Performance

  • At the commonly used 0.4 MoM cutoff, PAPP-A demonstrates a specificity of approximately 81.6%, with a positive likelihood ratio of only 2.1, indicating modest discriminatory power 1

  • At the more stringent 0.2 MoM cutoff, specificity improves substantially with a positive likelihood ratio of 3.7, though this identifies a much smaller proportion of at-risk pregnancies 2

  • At extremely low levels (≤0.1 MoM), the test becomes highly specific for adverse outcomes, though the absolute number of cases identified remains small 3

Clinical Interpretation of Specificity

The high specificity means that when PAPP-A is abnormally low (<0.4 MoM), there is genuine increased risk - approximately 2-fold for composite adverse outcomes including fetal growth restriction, preeclampsia, preterm delivery, and stillbirth 1. However, the poor sensitivity (38.7%) indicates that most adverse outcomes occur in women with normal PAPP-A levels, limiting its utility as a standalone screening test 1.

Positive and Negative Predictive Values

  • The positive predictive value is poor - even at very low PAPP-A levels (≤0.23 MoM), only 21.4% of pregnancies will experience adverse outcomes 2

  • The negative predictive value is high (97.7%), meaning normal PAPP-A levels are reassuring, though not absolute 2

  • At extremely low levels (≤0.2 MoM), good outcomes still occur in at least 60% of chromosomally normal pregnancies 3

Gestational Age Considerations

  • The 10-14 week gestational age window is the only period where low PAPP-A shows statistically significant association with adverse outcomes in adjusted models 1

  • Testing outside this window may have even lower predictive accuracy 1

Population-Specific Variations

Important caveat: The optimal cutoff may vary by ethnicity. Chinese populations demonstrate higher baseline PAPP-A levels, requiring adjustment of cutoff values for optimal performance 2. The standard 0.4 MoM cutoff derived from predominantly Caucasian populations may not perform equivalently across all ethnic groups 2.

Clinical Utility Despite Limited Specificity

Despite modest specificity as a standalone test, PAPP-A <0.4 MoM is recognized by international guidelines as warranting enhanced surveillance throughout pregnancy, including serial growth ultrasounds, uterine artery Doppler assessment, and consideration of low-dose aspirin when identified before 16 weeks 4. The value lies not in ruling in disease, but in identifying a higher-risk population requiring closer monitoring 4.

References

Research

Pregnancy-associated plasma protein A (PAPP-A) to predict adverse fetal outcomes in Chinese: What is the optimal cutoff value?

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2016

Research

Pregnancy outcome in the setting of extremely low first trimester PAPP-A levels.

The Australian & New Zealand journal of obstetrics & gynaecology, 2009

Guideline

PAPP-A Levels and Pregnancy Outcomes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.